View in EDS

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Saved in:
Bibliographic Details
Title: Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Authors: Coombes RC; Imperial College, South Kensington, London, UK., Howell S; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Lord SR; Early Phase Clinical Trials Unit, Department of Oncology, University of Oxford, Oxford, UK., Kenny L; Imperial College, South Kensington, London, UK., Mansi J; Guy's and St Thomas' NHS Foundation Trust, London, UK., Mitri Z; OHSU Knight Cancer Institute, Portland, OR, USA., Palmieri C; University of Liverpool, Liverpool, UK., Chap LI; University of California, Los Angeles, CA, USA., Richards P; Blue Ridge Cancer Center, Salem, VA, USA., Gradishar W; Northwestern University, Chicago, IL, USA., Sardesai S; US Oncology Research, OHC, Cincinnati, OH, USA., Melear J; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA., Ward P; US Oncology Research, OHC, Cincinnati, OH, USA., Chalasani P; University of Arizona Cancer Center, Tucson, AZ, USA., Arkenau T; Sarah Cannon Research Institute, London, UK., Baird RD; Cancer Research UK Cambridge Centre, Cambridge, UK., Jeselsohn R; Dana-Farber Cancer Institute, Boston, MA, USA., Ali S; Imperial College, South Kensington, London, UK., Clack G; Carrick Therapeutics, Dublin, Ireland., Bahl A; Carrick Therapeutics, Dublin, Ireland., McIntosh S; Carrick Therapeutics, Dublin, Ireland., Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. matthew.krebs@manchester.ac.uk.
Source: Nature communications [Nat Commun] 2025 Mar 06; Vol. 16 (1), pp. 2242. Date of Electronic Publication: 2025 Mar 06.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40050276
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Coombes+RC%22">Coombes RC</searchLink>; Imperial College, South Kensington, London, UK.<br /><searchLink fieldCode="AU" term="%22Howell+S%22">Howell S</searchLink>; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Lord+SR%22">Lord SR</searchLink>; Early Phase Clinical Trials Unit, Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kenny+L%22">Kenny L</searchLink>; Imperial College, South Kensington, London, UK.<br /><searchLink fieldCode="AU" term="%22Mansi+J%22">Mansi J</searchLink>; Guy's and St Thomas' NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Mitri+Z%22">Mitri Z</searchLink>; OHSU Knight Cancer Institute, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Palmieri+C%22">Palmieri C</searchLink>; University of Liverpool, Liverpool, UK.<br /><searchLink fieldCode="AU" term="%22Chap+LI%22">Chap LI</searchLink>; University of California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Richards+P%22">Richards P</searchLink>; Blue Ridge Cancer Center, Salem, VA, USA.<br /><searchLink fieldCode="AU" term="%22Gradishar+W%22">Gradishar W</searchLink>; Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Sardesai+S%22">Sardesai S</searchLink>; US Oncology Research, OHC, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Melear+J%22">Melear J</searchLink>; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22O'Shaughnessy+J%22">O'Shaughnessy J</searchLink>; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ward+P%22">Ward P</searchLink>; US Oncology Research, OHC, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Chalasani+P%22">Chalasani P</searchLink>; University of Arizona Cancer Center, Tucson, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Arkenau+T%22">Arkenau T</searchLink>; Sarah Cannon Research Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Baird+RD%22">Baird RD</searchLink>; Cancer Research UK Cambridge Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Jeselsohn+R%22">Jeselsohn R</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ali+S%22">Ali S</searchLink>; Imperial College, South Kensington, London, UK.<br /><searchLink fieldCode="AU" term="%22Clack+G%22">Clack G</searchLink>; Carrick Therapeutics, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Bahl+A%22">Bahl A</searchLink>; Carrick Therapeutics, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22McIntosh+S%22">McIntosh S</searchLink>; Carrick Therapeutics, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Krebs+MG%22">Krebs MG</searchLink>; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. matthew.krebs@manchester.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Mar 06; Vol. 16 (1), pp. 2242. <i>Date of Electronic Publication: </i>2025 Mar 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40050276
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-57535-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2242
    Titles:
      – TitleFull: Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Coombes RC
      – PersonEntity:
          Name:
            NameFull: Howell S
      – PersonEntity:
          Name:
            NameFull: Lord SR
      – PersonEntity:
          Name:
            NameFull: Kenny L
      – PersonEntity:
          Name:
            NameFull: Mansi J
      – PersonEntity:
          Name:
            NameFull: Mitri Z
      – PersonEntity:
          Name:
            NameFull: Palmieri C
      – PersonEntity:
          Name:
            NameFull: Chap LI
      – PersonEntity:
          Name:
            NameFull: Richards P
      – PersonEntity:
          Name:
            NameFull: Gradishar W
      – PersonEntity:
          Name:
            NameFull: Sardesai S
      – PersonEntity:
          Name:
            NameFull: Melear J
      – PersonEntity:
          Name:
            NameFull: O'Shaughnessy J
      – PersonEntity:
          Name:
            NameFull: Ward P
      – PersonEntity:
          Name:
            NameFull: Chalasani P
      – PersonEntity:
          Name:
            NameFull: Arkenau T
      – PersonEntity:
          Name:
            NameFull: Baird RD
      – PersonEntity:
          Name:
            NameFull: Jeselsohn R
      – PersonEntity:
          Name:
            NameFull: Ali S
      – PersonEntity:
          Name:
            NameFull: Clack G
      – PersonEntity:
          Name:
            NameFull: Bahl A
      – PersonEntity:
          Name:
            NameFull: McIntosh S
      – PersonEntity:
          Name:
            NameFull: Krebs MG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 03
              Text: 2025 Mar 06
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1